Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTA: Drug-eluting Stenting Versus Medical Treatment Alone for Patients With Extracranial Vertebral Artery Stenosis
NCT05885932Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Aug 2023
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in ischemic stroke and Vertebral artery stenosis (VBI) (2 arms), sponsored by Xuanwu Hospital. Primary endpoint: Any fatal or non-fatal stroke within 30 days, or ischemic stroke in the territory of the target artery beyond 30 days to 1 year. Started Aug 2023; status: recruiting.
02
Conditions
ischemic strokeVertebral artery stenosis (VBI)
Beyond the preview
Go deeper on NCT05885932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05885932.